prtx-100
Biologicalexperimental
Clinical trial activity
6 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2007 (NCT00517855)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- prtx-100
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02566603 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2015 | Protalex, Inc. |
| NCT02401061 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2015 | Protalex, Inc. |
| NCT02330445 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2015 | Protalex, Inc. |
| NCT01749787 | Phase 1 | Nov 1, 2012 | Protalex, Inc. |
| NCT00571467 | Phase 1 | Dec 1, 2007 | Protalex, Inc. |
| NCT00517855 | Phase 1 | Jun 1, 2007 | Buffalo Clinical Research Center, Protalex, Inc. |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Protalex, Inc. | For profit | 6 | 6 | 2 | 2007 |
| Buffalo Clinical Research Center | Academic/Hospital | 1 | 0 | 1 | 2007 |
2 organizations
Page 1 / 1